Advertisement

Journal of Community Health

, Volume 44, Issue 1, pp 61–67 | Cite as

Life Expectancy of Olympic Wrestling Champions in Comparison to the General Population

  • Karsten KellerEmail author
Original Paper

Abstract

Although it was presumed that moderate exercise is a healthy practice but long term high intensity exercise is not, studies observed a life expectancy benefit for both high-intensity endurance and fast power sports athlets, but the data for contact sports are conflicting. Therefore, the author aimed to investigate the life expectancy of Olympic wrestling champions in comparison to the general population. Characteristics, vital status and life-span of the male Olympic wrestling champions was collected (1896–2016). The life expectancy of Olympic champions was compared with matched individuals of the general population (by country, age, and year of birth) obtained from the human mortality database (http://www.mortality.org). Overall, 341 male Olympic wrestling champions with median age of 25 (IQR 24–28) years at their Olympic victory were included in this analysis. In total, 142 (41.6%) came of rich countries. The survival was not affected by weight class and country of origin. A significant life expectancy benefit for Olympic champions in comparison to the general population was observed. Male Olympic wrestling champions lived in mean 19.1 ± 19.1 years longer than the matched individuals of the general population (respectively of their country of origin). A substantially lower mortality in male Olympic wrestling champions, compared with the general male population was observed. However, the results do not allow us to draw conclusions about the causes of this survival benefit.

Keywords

Olympic champion Wrestling Life expectancy Wrestler Olympia 

Abbreviations

IQR

Interquartile range

Notes

Funding

This study was funded by the German Federal Ministry of Education and Research (BMBF 01EO1003 and BMBF 01EO1503) as an institutional Grant for the Center for Thrombosis and Hemostasis (University Medical Center Mainz, Mainz, Germany). The author is responsible for the contents of this publication.

Compliance with Ethical Standards

Conflict of interest

The author declares no conflict of interest.

Supplementary material

10900_2018_553_MOESM1_ESM.docx (12 kb)
Supplementary material 1 (DOCX 11 KB)

References

  1. 1.
    Berlin, J. A., & Colditz, G. A. (1990). A meta-analysis of physical activity in the prevention of coronary heart disease. American Journal of Epidemiology, 132, 612–628.CrossRefGoogle Scholar
  2. 2.
    Bianco, M., Fabbricatore, C., Sanna, N., Fabiano, C., Palmieri, V., & Zeppilli, P. (2007). Elite athletes: Is survival shortened in boxers? International Journal of Sports Medicine, 28, 697–702.CrossRefGoogle Scholar
  3. 3.
    Christensen, K., Doblhammer, G., Rau, R., & Vaupel, J. W. (2009). Ageing populations: The challenges ahead. Lancet, 374, 1196–1208.CrossRefGoogle Scholar
  4. 4.
    Clarke, P. M., Walter, S. J., Hayen, A., Mallon, W. J., Heijmans, J., & Studdert, D. M. (2012). Survival of the fittest: Retrospective cohort study of the longevity of Olympic medallists in the modern era. BMJ, 345, e8308.CrossRefGoogle Scholar
  5. 5.
    Haskell, W. L., Lee, I. M., Pate, R. R., Powell, K. E., Blair, S. N., Franklin, B. A., et al. (2007). Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation, 116, 1081–1093.CrossRefGoogle Scholar
  6. 6.
    Hubert, H. B., Feinleib, M., Mcnamara, P. M., & Castelli, W. P. (1983). Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation, 67, 968–977.CrossRefGoogle Scholar
  7. 7.
    Kettunen, J. A., Kujala, U. M., Kaprio, J., Bäckmand, H., Peltonen, M., Eriksson, J. G., et al. (2015). All-cause and disease-specific mortality among male, former elite athletes: An average 50-year follow-up. British Journal of Sports Medicine, 49, 893–897.CrossRefGoogle Scholar
  8. 8.
    Kley, H. K. (1992). Anabole steroide. In D. Clasing (Ed.), Doping—Verbotene Arzneimittel im Sport (pp. 43–78). Stuttgart: Gustav Fischer Verlag.Google Scholar
  9. 9.
    Lavie, C. J., Mcauley, P. A., Church, T. S., Milani, R. V., & Blair, S. N. (2014). Obesity and cardiovascular diseases: Implications regarding fitness, fatness, and severity in the obesity paradox. Journal of the American College of Cardiology, 63, 1345–1354.CrossRefGoogle Scholar
  10. 10.
    Manson, J. E., Tosteson, H., Ridker, P. M., Satterfield, S., Hebert, P., O’connor, G. T., et al. (1992). The primary prevention of myocardial infarction. The New England Journal of Medicine, 326, 1406–1416.CrossRefGoogle Scholar
  11. 11.
    Marijon, E., Tafflet, M., Antero-Jacquemin, J., El Helou, N., Berthelot, G., Celermajer, D. S., et al. (2013). Mortality of French participants in the Tour de France (1947–2012). European Heart Journal, 34, 3145–3150.CrossRefGoogle Scholar
  12. 12.
    Paffenbarger, R. S. Jr., Hyde, R. T., Wing, A. L., & Hsieh, C. C. (1986). Physical activity, all-cause mortality, and longevity of college alumni. The New England Journal of Medicine, 314, 605–613.CrossRefGoogle Scholar
  13. 13.
    Sanchis-Gomar, F., Olaso-Gonzalez, G., Corella, D., Gomez-Cabrera, M. C., & Vina, J. (2011). Increased average longevity among the “Tour de France” cyclists. International Journal of Sports Medicine, 32, 644–647.CrossRefGoogle Scholar
  14. 14.
    Sarna, S., Kaprio, J., Kujala, U. M., & Koskenvuo, M. (1997). Health status of former elite athletes. The Finnish experience. Aging (Milano), 9, 35–41.Google Scholar
  15. 15.
    Sarna, S., Sahi, T., Koskenvuo, M., & Kaprio, J. A. (1993). Increased life expectancy of world class male athletes. Medicine and Science in Sports and Exercise, 25, 237–244.CrossRefGoogle Scholar
  16. 16.
    Schnohr, P., Marott, J. L., Lange, P., & Jensen, G. B. (2013). Longevity in male and female joggers: The Copenhagen City Heart Study. American Journal of Epidemiology, 177, 683–689.CrossRefGoogle Scholar
  17. 17.
    Sjoqvist, F., Garle, M., & Rane, A. (2008). Use of doping agents, particularly anabolic steroids, in sports and society. Lancet, 371, 1872–1882.CrossRefGoogle Scholar
  18. 18.
    Yesalis, C. E., & Bahrke, M. S. (2000). Doping among adolescent athletes. Best Practice & Research Clinical Endocrinology & Metabolism, 14, 25–35.CrossRefGoogle Scholar
  19. 19.
    Yusuf, S., Hawken, S., Ounpuu, S., Bautista, L., Franzosi, M. G., Commerford, P., et al. (2005). Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: A case-control study. Lancet, 366, 1640–1649.CrossRefGoogle Scholar
  20. 20.
    Zwiers, R., Zantvoord, F. W., Engelaer, F. M., Van Bodegom, D., van der Ouderaa, F. J. G., & Westendorp, R. G. J. (2012). Mortality in former Olympic athletes: Retrospective cohort analysis. BMJ, 345, e7456.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Center for Thrombosis and Hemostasis (CTH)University Medical Center Mainz (Johannes Gutenberg-University Mainz)MainzGermany
  2. 2.Center of Cardiology, Cardiology IUniversity Medical Center Mainz (Johannes Gutenberg-University Mainz)MainzGermany
  3. 3.Team Doctor of the German Bundesliga Club 1. FSV Mainz 05 in the Soccer Season 2014/2015MainzGermany

Personalised recommendations